Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Pitroda

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Cell|May 26, 2023
YTHDF2 inhibition potentiates radiotherapy antitumor efficacyLiangliang Wang, Xiaoyang Dou, Shijie Chen, et al.
Nature Communications|February 26, 2020
Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancerYota Yasumizu, Hasan Rajabi, Caining Jin, et al.
Nature Communications|January 19, 2020
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancerYota Yasumizu, Hasan Rajabi, Caining Jin, et al.
The Journal of Clinical Investigation|September 26, 2024
YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN productionChuangyu Wen, Liangliang Wang, András Piffkó, et al.
Oncoimmunology|May 22, 2025
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad ConferenceFereshteh Talebi, Fabiana Gregucci, Jalal Ahmed, et al.
Oncoimmunology|June 26, 2023
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6<sup>th</sup> annual ImmunoRad conferenceFabiana Gregucci, Sheila Spada, Mary Helen Barcellos-Hoff, et al.
The Lancet. Oncology|March 6, 2025
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translationZachary S Morris, Sandra Demaria, Arta M Monjazeb, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Cell|May 26, 2023
YTHDF2 inhibition potentiates radiotherapy antitumor efficacyLiangliang Wang, Xiaoyang Dou, Shijie Chen, et al.
Nature Communications|February 26, 2020
Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancerYota Yasumizu, Hasan Rajabi, Caining Jin, et al.
Nature Communications|January 19, 2020
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancerYota Yasumizu, Hasan Rajabi, Caining Jin, et al.
The Journal of Clinical Investigation|September 26, 2024
YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN productionChuangyu Wen, Liangliang Wang, András Piffkó, et al.
Oncoimmunology|May 22, 2025
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad ConferenceFereshteh Talebi, Fabiana Gregucci, Jalal Ahmed, et al.
Oncoimmunology|June 26, 2023
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6<sup>th</sup> annual ImmunoRad conferenceFabiana Gregucci, Sheila Spada, Mary Helen Barcellos-Hoff, et al.
The Lancet. Oncology|March 6, 2025
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translationZachary S Morris, Sandra Demaria, Arta M Monjazeb, et al.
Pageof 2